← Back to Dashboard

Ribavirin

Nucleoside inhibitor; Guanosine (ribonucleic) analog · Nucleoside inhibitor Guanosine (ribonucleic) analog

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N
IWUCXVSUMQZMFG-AFCXAGJDSA-N

Clinical Development by Virus23

Human orthopneumovirus
RSV
Target: Viral RNA pol
FDA approved
Preclinical
Phase 2negative
Phase 3
Approved
FDAJapanChinaRussia
Hepacivirus C
HCV
Target: NS5A phosphoprotein
FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDAJapanChinaRussia
Orthohepevirus A
HEV
Target: Viral RNA pol
FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDAJapanChinaRussia
Lassa mammarenavirus
LASV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
JapanChinaRussia
Rubivirus rubellae
RuV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
JapanChinaRussia
Chikungunya virus
CHIKV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Mamastrovirus 1
HAstV-4
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
JapanChinaRussia
Mamastrovirus 9
Ast-VA1
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
JapanChinaRussia
Human orthorubulavirus 2
HPIV-2
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
JapanChinaRussia
Measles morbillivirus
MeV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Rabies lyssavirus
RABV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Dengue virus
DENV-1
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Dengue virus
DENV-2
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Dengue virus
DENV-4
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Japanese encephalitis virus
JEV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
West Nile virus
WNV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Yellow fever virus
YFV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Zika virus
ZIKV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Usutu virus
USUV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Langat virus
LGTV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Wesselsbron virus
WESSV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan